SCHEMBL24834846

SCHEMBL24834846

CN(C)C(=O)c1nn2c(=O)cc(-c3ccc(C4CCCCC4)cc3)[nH]c2c1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
HSP90AA1 P07900 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
BIRC5 O15392 2/20 0.35
FASN P49327 9/20 0.34
PLAT P00750 3/20 0.33
PDE9A O76083 1/20 0.33
KDM1A O60341 1/20 0.32
PRKAB2 O43741 1/20 0.32
PRKAG1 P54619 1/20 0.32
PRKAA2 P54646 1/20 0.32
PRKAA1 Q13131 1/20 0.32
PRKAG3 Q9UGI9 1/20 0.32
PRKAG2 Q9UGJ0 1/20 0.32
PRKAB1 Q9Y478 1/20 0.32
MEN1 O00255 1/20 0.31
NSD2 O96028 1/20 0.31
TRPV4 Q9HBA0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23415026 0.89 KMT2A (0.40) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL24835398 0.87 MAPT (0.37) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL24834777 0.85 KMT2A (0.38) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL24834776 0.84 HSP90AA1 (0.38) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL24834839 0.82 PLAT (0.47) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL24834869 0.80 GAA (0.39) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL23699993 0.78 HSP90AA1 (0.40) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL23415021 0.78 PLAT (0.34) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL23700008 0.77 PLAT (0.39) KMT2AHSP90AA1GAAMAPTTDP1
SCHEMBL23700026 0.75 PLAT (0.39) KMT2AHSP90AA1GAAMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002396-A1 THERAPEUTIC COMPOUNDS GENENTECH, INC. (US) 2023-01-05 US disclosed
US-20230002396-A1 THERAPEUTIC COMPOUNDS GENENTECH, INC. (US) 2023-01-05 US disclosed
CN-114786778-A Therapeutic compounds 基因泰克公司 2022-07-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002396-A1 THERAPEUTIC COMPOUNDS YAP1, YES1, TEAD2 KMT2A 3482/4885HSP90AA1 472/4885GAA 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.